LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.

Papadopoulos, Grigorios / Legaki, Aigli-Ioanna / Georgila, Konstantina / Vorkas, Panagiotis / Giannousi, Eirini / Stamatakis, George / Moustakas, Ioannis I / Petrocheilou, Maria / Pyrina, Iryna / Gercken, Bettina / Kassi, Eva / Chavakis, Triantafyllos / Pateras, Ioannis S / Panayotou, George / Gika, Helen / Samiotaki, Martina / Eliopoulos, Aristides G / Chatzigeorgiou, Antonios

Metabolism: clinical and experimental

2023  Volume 144, Page(s) 155552

Abstract: Background: High-Fructose Corn Syrup (HFCS), a sweetener rich in glucose and fructose, is nowadays widely used in beverages and processed foods; its consumption has been correlated to the emergence and progression of Non-Alcoholic Fatty Liver Disease ( ... ...

Abstract Background: High-Fructose Corn Syrup (HFCS), a sweetener rich in glucose and fructose, is nowadays widely used in beverages and processed foods; its consumption has been correlated to the emergence and progression of Non-Alcoholic Fatty Liver Disease (NAFLD). Nevertheless, the molecular mechanisms by which HFCS impacts hepatic metabolism remain scarce, especially in the context of obesity. Besides, the majority of current studies focuses either on the detrimental role of fructose in hepatic steatosis or compare separately the additive impact of fructose versus glucose in high fat diet-induced NAFLD.
Aim: By engaging combined omics approaches, we sought to characterize the role of HFCS in obesity-associated NAFLD and reveal molecular processes, which mediate the exaggeration of steatosis under these conditions.
Methods: Herein, C57BL/6 mice were fed a normal-fat-diet (ND), a high-fat-diet (HFD) or a HFD supplemented with HFCS (HFD-HFCS) and upon examination of their metabolic and NAFLD phenotype, proteomic, lipidomic and metabolomic analyses were conducted to identify HFCS-related molecular alterations of the hepatic metabolic landscape in obesity.
Results: Although HFD and HFD-HFCS mice displayed comparable obesity, HFD-HFCS mice showed aggravation of hepatic steatosis, as analysis of the lipid droplet area in liver sections revealed (12,15 % of total section area in HFD vs 22,35 % in HFD-HFCS), increased NAFLD activity score (3,29 in HFD vs 4,86 in HFD-HFCS) and deteriorated hepatic insulin resistance, as compared to the HFD mice. Besides, the hepatic proteome of HFD-HFCS mice was characterized by a marked upregulation of 5 core proteins implicated in de novo lipogenesis (DNL), while an increased phosphatidyl-cholines(PC)/phosphatidyl-ethanolamines(PE) ratio (2.01 in HFD vs 3.04 in HFD-HFCS) was observed in the livers of HFD-HFCS versus HFD mice. Integrated analysis of the omics datasets indicated that Tricarboxylic Acid (TCA) cycle overactivation is likely contributing towards the intensification of steatosis during HFD-HFCS-induced NAFLD.
Conclusion: Our results imply that HFCS significantly contributes to steatosis aggravation during obesity-related NAFLD, likely deriving from DNL upregulation, accompanied by TCA cycle overactivation and deteriorated hepatic insulin resistance.
MeSH term(s) Mice ; Animals ; Non-alcoholic Fatty Liver Disease/genetics ; Non-alcoholic Fatty Liver Disease/metabolism ; High Fructose Corn Syrup/adverse effects ; High Fructose Corn Syrup/metabolism ; Insulin Resistance/genetics ; Proteomics ; Mice, Inbred C57BL ; Liver/metabolism ; Obesity/genetics ; Obesity/metabolism ; Fructose/adverse effects ; Fructose/metabolism ; Glucose/metabolism ; Diet, High-Fat/adverse effects
Chemical Substances High Fructose Corn Syrup ; Fructose (30237-26-4) ; Glucose (IY9XDZ35W2)
Language English
Publishing date 2023-03-28
Publishing country United States
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 80230-x
ISSN 1532-8600 ; 0026-0495
ISSN (online) 1532-8600
ISSN 0026-0495
DOI 10.1016/j.metabol.2023.155552
Shelf mark
Uc I Zs.316: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top